AU1462992A - Agglutination assay - Google Patents

Agglutination assay

Info

Publication number
AU1462992A
AU1462992A AU14629/92A AU1462992A AU1462992A AU 1462992 A AU1462992 A AU 1462992A AU 14629/92 A AU14629/92 A AU 14629/92A AU 1462992 A AU1462992 A AU 1462992A AU 1462992 A AU1462992 A AU 1462992A
Authority
AU
Australia
Prior art keywords
agglutination assay
agglutination
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14629/92A
Inventor
James Francis Kelly
Peter David Weston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Murex Technologies Corp
Original Assignee
International Murex Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Murex Technologies Corp filed Critical International Murex Technologies Corp
Publication of AU1462992A publication Critical patent/AU1462992A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU14629/92A 1991-04-04 1992-04-06 Agglutination assay Abandoned AU1462992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9107030 1991-04-04
GB919107030A GB9107030D0 (en) 1991-04-04 1991-04-04 Assay

Publications (1)

Publication Number Publication Date
AU1462992A true AU1462992A (en) 1992-11-02

Family

ID=10692609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14629/92A Abandoned AU1462992A (en) 1991-04-04 1992-04-06 Agglutination assay

Country Status (4)

Country Link
AU (1) AU1462992A (en)
GB (1) GB9107030D0 (en)
IE (1) IE921089A1 (en)
WO (1) WO1992017781A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192778B2 (en) 1999-10-06 2007-03-20 Natan Michael J Surface enhanced spectroscopy-active composite nanoparticles
US8497131B2 (en) 1999-10-06 2013-07-30 Becton, Dickinson And Company Surface enhanced spectroscopy-active composite nanoparticles comprising Raman-active reporter molecules
US6861263B2 (en) 2001-01-26 2005-03-01 Surromed, Inc. Surface-enhanced spectroscopy-active sandwich nanoparticles
DE102004033811A1 (en) * 2004-07-12 2006-02-02 Salama, Abdulgabar, Prof. Dr. Method for the simple and rapid detection of cells and biomolecules with the aid of paramagnetic particles
US8409863B2 (en) 2005-12-14 2013-04-02 Becton, Dickinson And Company Nanoparticulate chemical sensors using SERS
US7723100B2 (en) 2006-01-13 2010-05-25 Becton, Dickinson And Company Polymer coated SERS nanotag
FR2963108B1 (en) 2010-07-21 2017-06-23 Diagast MAGNETIC IMMUNODIAGNOSTIC METHOD AND KIT FOR THE EVIDENCE OF BLOOD GROUP / BLOOD PHENOTYPE ANTIBODY / ANTIGEN COMPLEX
FR2963107B1 (en) 2010-07-21 2019-06-28 Diagast IMMUNO MAGNETIC COMPLEX AND ITS USE FOR ERYTHROCYTE GROUPING / PHENOTYPING
US10895571B2 (en) * 2013-06-06 2021-01-19 Siemens Healthineers Nederland B.V. Reagents, methods and devices to prevent aggregation in particle based tests for the detection of multimeric target molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115535A (en) * 1977-06-22 1978-09-19 General Electric Company Diagnostic method employing a mixture of normally separable protein-coated particles
US4791067A (en) * 1987-06-25 1988-12-13 Fisher Scientific Co. Agglutination immunoassay for hapten involving monoclonal antibody of IgA class reagent
GB8717862D0 (en) * 1987-07-28 1987-09-03 Acade Diagnostic Systems Sa Nv Turbidimetric assay
JPH02210262A (en) * 1989-02-10 1990-08-21 Shinotesuto Kenkyusho:Kk Method for indirectly measuring flocculation reaction

Also Published As

Publication number Publication date
GB9107030D0 (en) 1991-05-22
IE921089A1 (en) 1992-10-07
WO1992017781A1 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
AU2464892A (en) Assay method
AU7903694A (en) Assays
AU1823492A (en) Imidazodiazepines
AU2121092A (en) Benzodioxanderivate
AU1930992A (en) Pyrrolopyrazines
AU1716292A (en) Assay of specific antibody
AU1782292A (en) Gridbeam
AU2135292A (en) Cyanophenylpyrroles
AU1773692A (en) Rapamycin assay
AU1556892A (en) 2-substituted-2-imidazolines
GB9105707D0 (en) Assay
AU1080292A (en) Ige-receptor-antibodies
AU1462992A (en) Agglutination assay
AU1104092A (en) Agglutination immunoassay
AU1752492A (en) Diamino-alpha-alkylstilbenes
AP9000208A0 (en) Agglutination assay
AU1732692A (en) Substituted imidazolinylpyrimidines
AU3092592A (en) Pipetter
AU2040192A (en) Quinolin-2-yl-methoxybenzylhydroxyureas
GB9107983D0 (en) Assays
AU2361992A (en) Sample evaluation
AU1588892A (en) Watch-strap
AU1624092A (en) Mopheads
AU1669792A (en) Azabicycloheptanone
AU2521192A (en) Polyolefin-polyamine-N-substituted poly-carbamates